• OneMedNet signed a seven-figure, multiyear deal to supply de-identified longitudinal clinical real-world data via its iRWD platform.
• Customer will use the data to train AI clinical models, then sell a derivative dataset that links molecular data with OneMedNet imaging.
• Contract includes recurring sublicensing revenue for OneMedNet on each downstream end-customer license, on top of the initial license fee.
• Agreement includes an option to expand data volume, raising potential contract value over time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609300855PRIMZONEFULLFEED9836910) on September 30, 2026, and is solely responsible for the information contained therein.